A vs AMLX: Which Stock is Better?

Side-by-side comparison of Agilent Technologies Inc and Amylyx Pharmaceuticals Inc in 2026

Comparison Updated:

A

Agilent Technologies Inc

$120.39

AMLX

Amylyx Pharmaceuticals Inc

$16.47

Key Metrics Comparison

MetricAAMLXWinner
Market Cap$34.05B$1.81BA
P/E Ratio25.89N/AA
EPS (TTM)$4.65$N/AA
Revenue Growth0.1%-1.0%A
Gross Margin52.3%13594.6%AMLX

Analyze A

Full quant analysis

Analyze AMLX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is A or AMLX a better investment?

Comparing A and AMLX: Agilent Technologies Inc has a market cap of $34.05B while Amylyx Pharmaceuticals Inc has $1.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between A and AMLX?

A (Agilent Technologies Inc) and AMLX (Amylyx Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: A or AMLX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: A or AMLX?

A has higher revenue growth at 0.1% vs -1.0% for AMLX.

Which company is more profitable: A or AMLX?

Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 13594.6% compared to 52.3% for A.

Which is the larger company: A or AMLX?

Agilent Technologies Inc (A) is larger with a market cap of $34.05B compared to $1.81B for AMLX.

Should I buy A or AMLX in 2026?

Both A and AMLX have investment merit. A trades at $120.39 while AMLX trades at $16.47. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between A and AMLX stock?

Key differences: Market Cap ($34.05B vs $1.81B), P/E Ratio (25.9x vs N/A), Revenue Growth (0.1% vs -1.0%), Gross Margin (52.3% vs 13594.6%).

Popular Stock Comparisons